Intracellular Calcium Leak Due to FKBP12.6 Deficiency in Mice Facilitates the Inducibility of Atrial Fibrillation

Overview

Journal Heart Rhythm

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2008 Jul 5

PMID 18598963

Citations 77

Authors

Subeena Sood

Mihail G Chelu

Ralph J van Oort

Darlene Skapura

Marco Santonastasi

Dobromir Dobrev

Xander H T Wehrens

Affiliations

Soon will be listed here.

Abstract

Background: Although defective Ca(2+) homeostasis may contribute to arrhythmogenesis in atrial fibrillation (AF), the underlying molecular mechanisms remain poorly understood. Studies in patients with AF revealed that impaired diastolic closure of sarcoplasmic reticulum (SR) Ca(2+)-release channels (ryanodine receptors, RyR2) is associated with reduced levels of the RyR2-inhibitory subunit FKBP12.6.

Objective: The objective of the present study was to test the hypothesis that Ca(2+) leak from the SR through RyR2 increases the propensity for AF in FKBP12.6-deficient (-/-) mice.

Methods: Surface electrocardiogram and intracardiac electrograms were recorded simultaneously in FKBP12.6-/- mice and wild-type (WT) littermates. Right atrial programmed stimulation was performed before and after injection of RyR2 antagonist tetracaine (0.5 mg/kg). Intracellular Ca(2+) transients were recorded in atrial myocytes from FKBP12.6-/- and WT mice.

Results: FKBP12.6-/- mice had structurally normal atria and unaltered expression of key Ca(2+)-handling proteins. AF episodes were inducible in 81% of FKBP12.6-/-, but in only 7% of WT mice (P <.05), and were prevented by tetracaine in all FKBP12.6-/- mice. SR Ca(2+) leak in FKBP12.6-/- myocytes was 53% larger than in WT myocytes, and FKBP12.6-/- myocytes showed increased incidence of spontaneous SR Ca(2+) release events, which could be blocked by tetracaine.

Conclusion: The increased vulnerability to AF in FKBP12.6-/- mice substantiates the notion that defective SR Ca(2+) release caused by abnormal RyR2 and FKBP12.6 interactions may contribute to the initiation or maintenance of atrial fibrillation.

Citing Articles

SGLT2 inhibitors protect against diabetic cardiomyopathy and atrial fibrillation through a CaMKII independent mechanism.

Severino A, Reyes-Gaido O, Nguyen P, Elkarim A, Luczak E, Mesubi O bioRxiv. 2024; .

PMID: 39386626 PMC: 11463538. DOI: 10.1101/2024.09.23.614368.

Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders.

Miotto M, Reiken S, Wronska A, Yuan Q, Dridi H, Liu Y Nat Commun. 2024; 15(1):8080.

PMID: 39278969 PMC: 11402997. DOI: 10.1038/s41467-024-51791-y.

Aging-associated atrial fibrillation: A comprehensive review focusing on the potential mechanisms.

Wang M, Hou C, Jia F, Zhong C, Xue C, Li J Aging Cell. 2024; 23(10):e14309.

PMID: 39135295 PMC: 11464128. DOI: 10.1111/acel.14309.

In Vivo Cardiac Electrophysiology in Mice: Determination of Atrial and Ventricular Arrhythmic Substrates.

Navarro-Garcia J, Bruns F, Moore O, Tekook M, Dobrev D, Miyake C Curr Protoc. 2024; 4(2):e994.

PMID: 38372479 PMC: 10883620. DOI: 10.1002/cpz1.994.

Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease.

Jurisic S, Medeiros-Domingo A, Berger F, Balmer C, Brunckhorst C, Ruschitzka F J Clin Med. 2024; 13(1).

PMID: 38202054 PMC: 10779837. DOI: 10.3390/jcm13010047.

References

Schrickel J, Bielik H, Yang A, Schimpf R, Shlevkov N, Burkhardt D . Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res Cardiol. 2002; 97(6):452-60. DOI: 10.1007/s003950200052. View

Curran J, Hinton M, Rios E, Bers D, R Shannon T . Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res. 2007; 100(3):391-8. DOI: 10.1161/01.RES.0000258172.74570.e6. View

Mitchell G, Jeron A, Koren G . Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998; 274(3):H747-51. DOI: 10.1152/ajpheart.1998.274.3.H747. View

Kovoor P, Wickman K, Maguire C, Pu W, Gehrmann J, Berul C . Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol. 2001; 37(8):2136-43. DOI: 10.1016/s0735-1097(01)01304-3. View

Wehrens X, Lehnart S, Huang F, Vest J, Reiken S, Mohler P . FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 2003; 113(7):829-40. DOI: 10.1016/s0092-8674(03)00434-3. View

Zahradnikova A, Palade P . Procaine effects on single sarcoplasmic reticulum Ca2+ release channels. Biophys J. 1993; 64(4):991-1003. PMC: 1262417. DOI: 10.1016/S0006-3495(93)81465-6. View

Wehrens X, Marks A . Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nat Rev Drug Discov. 2004; 3(7):565-73. DOI: 10.1038/nrd1440. View

Vest J, Wehrens X, Reiken S, Lehnart S, Dobrev D, Chandra P . Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 2005; 111(16):2025-32. DOI: 10.1161/01.CIR.0000162461.67140.4C. View

Nattel S . New ideas about atrial fibrillation 50 years on. Nature. 2002; 415(6868):219-26. DOI: 10.1038/415219a. View

10.

Venetucci L, Trafford A, Diaz M, ONeill S, Eisner D . Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes. Circ Res. 2006; 98(10):1299-305. DOI: 10.1161/01.RES.0000222000.35500.65. View

11.

R Shannon T, Ginsburg K, Bers D . Quantitative assessment of the SR Ca2+ leak-load relationship. Circ Res. 2002; 91(7):594-600. DOI: 10.1161/01.res.0000036914.12686.28. View

12.

Wehrens X, Lehnart S, Reiken S, Deng S, Vest J, Cervantes D . Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science. 2004; 304(5668):292-6. DOI: 10.1126/science.1094301. View

13.

Li X, Zima A, Sheikh F, Blatter L, Chen J . Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Circ Res. 2005; 96(12):1274-81. DOI: 10.1161/01.RES.0000172556.05576.4c. View

14.

Wijffels M, Kirchhof C, Dorland R, Allessie M . Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995; 92(7):1954-68. DOI: 10.1161/01.cir.92.7.1954. View

15.

Burashnikov A, Antzelevitch C . Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation. 2003; 107(18):2355-60. DOI: 10.1161/01.CIR.0000065578.00869.7C. View

16.

Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S . Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol. 2007; 582(Pt 2):675-93. PMC: 2075332. DOI: 10.1113/jphysiol.2006.126714. View

17.

Qu Z, Weiss J . Dynamics and cardiac arrhythmias. J Cardiovasc Electrophysiol. 2006; 17(9):1042-9. DOI: 10.1111/j.1540-8167.2006.00567.x. View

18.

Verheule S, Sato T, Everett 4th T, Engle S, Otten D, Rubart-von der Lohe M . Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res. 2004; 94(11):1458-65. PMC: 2129102. DOI: 10.1161/01.RES.0000129579.59664.9d. View

19.

Kumagai K, Nakashima H, Gondo N, Saku K . Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. J Cardiovasc Electrophysiol. 2003; 14(8):880-4. DOI: 10.1046/j.1540-8167.2003.03050.x. View

20.

Kannankeril P, Mitchell B, Goonasekera S, Chelu M, Zhang W, Sood S . Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci U S A. 2006; 103(32):12179-84. PMC: 1567715. DOI: 10.1073/pnas.0600268103. View